Altogether, these results suggest that both Bcl‐xL mRNA and protein were over‐expressed in Ph‐ MPN independently from the JAK2 mutational status and correlated with the clinical severity of the diseases. The gene discussed is BCL2L1; the disease is myeloproliferative neoplasm.